chr9-78297217-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_058179.4(PSAT1):c.7G>T(p.Ala3Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000418 in 1,601,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A3T) has been classified as Uncertain significance.
Frequency
Consequence
NM_058179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSAT1 | NM_058179.4 | c.7G>T | p.Ala3Ser | missense_variant | 1/9 | ENST00000376588.4 | |
PSAT1 | NM_021154.5 | c.7G>T | p.Ala3Ser | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSAT1 | ENST00000376588.4 | c.7G>T | p.Ala3Ser | missense_variant | 1/9 | 1 | NM_058179.4 | P1 | |
PSAT1 | ENST00000347159.6 | c.7G>T | p.Ala3Ser | missense_variant | 1/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152176Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000833 AC: 19AN: 228132Hom.: 0 AF XY: 0.0000959 AC XY: 12AN XY: 125108
GnomAD4 exome AF: 0.0000428 AC: 62AN: 1449014Hom.: 0 Cov.: 36 AF XY: 0.0000597 AC XY: 43AN XY: 720770
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152176Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74344
ClinVar
Submissions by phenotype
Neu-Laxova syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 14, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect PSAT1 function (PMID: 32077105). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 976926). This variant has not been reported in the literature in individuals affected with PSAT1-related conditions. This variant is present in population databases (rs776757559, gnomAD 0.05%). This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 3 of the PSAT1 protein (p.Ala3Ser). - |
not provided Other:1
not provided, no classification provided | in vivo;research | Dudley Research Group, Pacific Northwest Research Institute | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at